177 results on '"Nout, R.A."'
Search Results
2. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors
3. Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy
4. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
5. Impact of transitioning to an online course – A report from the ESTRO gyn teaching course
6. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study
7. Acute toxicity results from a multicenter randomized phase 3 trial comparing external beam radiotherapy alone with external beam radiotherapy combined with brachytherapy in intermediate/high risk prostate cancer patients
8. Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer Survivors
9. Robustness Settings for a Plan-of-the-Day IMPT Strategy for Locally Advanced Cervical Cancer
10. Global Collaborations for Cervical Cancer: Can the East–West Alliance Facilitate Treatment for all?
11. Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
12. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study
13. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
14. Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer
15. OC-0508 Molecular classification of endometrial cancer is predictive of response to adjuvant radiotherapy
16. OC-0605 Patient-reported peripheral neuropathy in cervix cancer patients: a trajectory analysis
17. Practical guidance for mismatch repair-deficiency testing in endometrial cancer
18. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects
19. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
20. Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
21. Vaginal brachytherapy management of stage I and II endometrial cancer
22. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy
23. OC-0296 Risk factors for severe gastrointestinal morbidity in locally advanced cervix cancer (EMBRACE study)
24. P-72 Hypofractionated, Dose redistributed RAdiotherapy for head and neck squamous cell carcinoma (HYDRA)
25. P087 - Acute toxicity results from a multicenter randomized phase 3 trial comparing external beam radiotherapy alone with external beam radiotherapy combined with brachytherapy in intermediate/high risk prostate cancer patients
26. Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer
27. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
28. Radiation-induced morphological changes in the vagina
29. Pattern of failure in IDH mutated, low grade glioma after radiotherapy – Implications for margin reduction
30. Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP:Target concept for image guided adaptive brachytherapy in primary vaginal cancer
31. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
32. OC-1049: Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer
33. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3
34. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
35. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
36. Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
37. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
38. Treatment toxicity in endometrial cancer: can we identify and manage it better?
39. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
40. Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer
41. Sexual Activity and Vaginal Functioning in Patients with Locally Advanced Cervical Cancer following Definitive Radiochemotherapy and Image-Guided Adaptive Brachytherapy (EMBRACE Study)
42. PV-0368 Persistence of late substantial patient reported symptoms (LAPERS): A report from the EMBRACE study
43. OC-0506 Patient-reported sexual outcomes after definitive RCHT+IGABT for cervical cancer (EMBRACE study)
44. Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials Reply
45. Benefit of repeat CT in high-dose rate brachytherapy as radical treatment for rectal cancer
46. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
47. Implementatie en quality assurance van state-of-the-art radiotherapie voor gevorderd cervixcarcinoom in Nederland: een kwaliteitsbevorderingsproject
48. PO-0867: Reporting of late morbidity after radiotherapy: review of the current practice in large studies
49. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer
50. OC-0280: Proctitis after brachytherapy for rectal cancer: clinical and dosimetric factors - The HERBERT study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.